Browse full report: https://marketsnresearch.com/report/1465/global-oxygen-therapy-market
Oxygen therapy has become the need of an hour due to increasing COVID-19 cases that demand oxygen for critically ill patients and in initial stages of the virus growth in the body. Thereby there has been surging need overall the globe for devices that can supply oxygen to the body. As there has been a shortage of ventilators, the oxygen therapy devices have been used to treat COVID-19 patients having mild breathlessness. Additionally, oxygen therapy devices can provide relief to patients and increasing lung disorders are also the contributing factors towards the demand of oxygen therapy which can eventually lead to healthy lifestyle. These factors are going to increase the growth as well as disposable income of the market globally.
Several types of oxygen therapies include oxygen gas, liquid oxygen, oxygen concentrators and hyperbaric oxygen therapy. Among these types, the oxygen gas is more prominent as it is highly effective and harmless to use as it is stored in a portable tanks and can be more efficiently used for treating patients as oxygen is provided in a pulse manner and not continuously.
Leading companies operating in the oxygen therapy provision are working towards providing the safest and best relief outcomes for respiratory disease patients. Some of the prominent players of the market include Becton, Dickinson and Company, General Electric Company (GE Healthcare), HERSILL, S.L., Philips Respironics, Inc., DeVilbiss Healthcare LLC, MedWrench, LLC, Smiths Group plc (Smiths Medical), Allied Healthcare Products, Inc., Fisher & Paykel Healthcare Limited, Teleflex Incorporated and Invacare Corporation.
Trends and Future Outlook:
- In February 2021, HERSILL, S.L. has launched a new device OXYLL 70L/min, an oxygen flow meter which provides high amount of oxygen flow along with an active humidification equipment. Thereby this device has been designed specifically to provide support for COVID-19 patients.